Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 241
References Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F. 2001. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45(7):2054–9. Abdel-Wahab MF. 1982. Schistosomiasis in Egypt. Boca Raton, FL: CRC Press, Inc. Acosta CJ, Galindo CM, Kimario J, Senkoro K, Urassa H, Casals C, Corachan M, Eseko N, Tanner M, Mshinda H, Lwilla F, Vila J, Alonso PL. 2001. Cholera outbreak in southern Tanzania: risk factors and patterns of transmission . Emerg Infect Dis 7(3 Suppl):583–7. Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE. 2001. Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 10(3):265–73. Adeyi O, Hecht R, Njobvu E, Soucat A. 2001. AIDS, Poverty Reduction and Debt Relief: Toolkit for Mainstreaming HIV/AIDS Programmes into Development Instruments. UNAIDS/01.01E. Geneva: UNAIDS. Afonso CL, Tulman ER, Lu Z, Balinsky CA, Moser BA, Becnel JJ, Rock DL, Kutish GF. 2001. Genome sequence of a baculovirus pathogenic for Culex nigripalpus. J Virol 75(22):11157–65. Ahmad K. 2000. More deaths from Rift Valley fever in Saudi Arabia and Yemen. Lancet 356(9239):1422. Alibek K. 1999. The Soviet Union’s anti-agricultural biological weapons. Ann N Y Acad Sci 894:18–9. Alibek K., Handelman S. 2000. Biohazard. New York: Delta Books. Alliance for the Prudent Use of Antibiotics (APUA). 2001. Antibiotic resistance: synthesis of recommendations by expert policy groups. WHO/CDS/CSR/DRS/2001.10. Geneva: WHO. APUA. 2002. The Need to Improve Antimicrobial Use in Agriculture: Ecological and Human Health Consequences. Executive Summary. [Online]. Available: http://www.healthsci.tufts.edu/apua/Ecology/faairExecSum_6–02.html#ExSum [accessed June 13, 2002].
OCR for page 242
Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A. 2002. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long–term follow up (1989–January 1997). J Intern Med 251(2):119–28. Alphey L, Beard CB, Billingsley P, Coetzee M, Crisanti A, Curtis C, Eggleston P, Godfray C, Hemingway J, Jacobs–Lorena M, James AA, Kafatos FC, Mukwaya LG, Paton M, Powell JR, Schneider W, Scott TW, Sina B, Sinden R, Sinkins S, Spielman A, Toure Y, Collins FH. 2002. Malaria control with genetically manipulated insect vectors. Science 298(5591):119–21. Alterholt TB, LeChevalier MW, Norton WD, Rosen JS. 1998. Effect of rainfall on giardia and crypto. J Am Water Works Assoc 90:66–80. American Social Health Association. 1998. Sexually Transmitted Disease in America: How Many Cases and at What Cost? Menlo Park, CA: Kaiser Family Foundation. American Social Health Association. 2001. HPV Background Information. [Online]. Available: http://www.ashastd.org/hpvccrc/background.html [accessed March 5, 2003]. Animal and Plant Health Inspection Service (APHIS). 1992. The Foreign Animal Disease Diagnostic Laboratory at Plum Island Animal Disease Center. [Online]. Available: http://www.aphis.usda.gov/oa/pubs/fsfadlab.html [accessed January 29, 2003]. APHIS. 1999a. Poultry and Eggs. Washington, DC: U.S. Department of Agriculture. APHIS. 1999b. Factsheet: Invasive Species. Washington, DC: U.S. Department of Agriculture. APHIS. 2002. Chronic Wasting Disease. [Online]. Available: http://www.aphis.usda.gov/lpa/issues/cwd/cwd.html [accessed February 22, 2003]. Aoki T. 1988. Drug-resistant plasmids from fish pathogens. Microbiol Sci 5(7):219–23. Aral S. 1999. Elimination and reintroduction of a sexually transmitted disease: lessons to be learned? Am J Public Health 89(7):995–7. Armstrong GL, Conn LA, Pinner RW. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281(1):61–6. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O’Toole T, Parker G, et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285(8):1059–70. Asthana S, Oostvogels R. 1996. Community participation in HIV prevention: problems and prospects for community-based strategies among female sex workers in Madras. Soc Sci Med 43(2):133–48. Attaran A, Roberts DR, Curtis CF, Kilama WL. 2000. Balancing risks on the backs of the poor . Nat Med 6(7):729–31. Baier EG. 1997. The Impact of HIV/AIDS on Rural Households/Communities and the Need for Multisectoral Prevention and Mitigation Strategies to Combat the Epidemic in Rural Areas. Rome: Food and Agriculture Organization of the United Nations. Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL. 2002. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 156(2):121–6. Barbour AG, Fish D. 1993. The biological and social phenomenon of Lyme disease. Science 260(5114):1610–6. Barclay AJ, Foster A, Sommer A. 1987. Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J (Clin Res Ed) 294(6567):294–6. Barragan A, Kremsner PG, Wahlgren M, Carlson J. 2000. Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infect Immun 68(5):2971–5. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. 1998. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 26(4):811–38.
OCR for page 243
Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. 2000. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31(2):347–82. Beard CB, Cordon–Rosales C, Durvasula RV. 2002. Bacterial symbionts of the triatominae and their potential use in control of Chagas disease transmission. Annu Rev Entomol 47:123–41. Beaty BJ. 2000. Genetic manipulation of vectors: a potential novel approach for control of vector-borne diseases. Proc Natl Acad Sci U S A 97(19):10295–7. Belgrader P, Benett W, Hadley D, Long G, Mariella R Jr, Milanovich F, Nasarabadi S, Nelson W, Richards J, Stratton P. 1998. Rapid pathogen detection using a microchip PCR array instrument. Clin Chem 44(10):2191–4. Belgrader P, Hansford D, Kovacs GT, Venkateswaran K, Mariella R Jr, Milanovich F, Nasarabadi S, Okuzumi M, Pourahmadi F, Northrup MA. 1999a. A minisonicator to rapidly disrupt bacterial spores for DNA analysis. Anal Chem 71(19):4232–6. Belgrader P, Benett W, Hadley D, Richards J, Stratton P, Mariella R Jr, Milanovich F. 1999b. PCR detection of bacteria in seven minutes. Science 284(5413):449–50. Bellini WJ, Rota PA. 1998. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 4(1):29–35. Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. 1997. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 337(6):388–94. Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. 2000. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol 18(10):1060–4. Bergeron MG, Ouellette M. 1998. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect Control Hosp Epidemiol 19(8):560–4. Berkman LF, Kawachi I, eds. 2000. Social Epidemiology. New York: Oxford University Press. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. 1999. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17(1):82– 94. Bez C, Lodi G, Scully C, Porter SR. 2000. Genoprevalence of TT virus among clinical and auxiliary UK dental healthcare workers: a pilot study. Br Dent J 189(10):554–5. Bhargava A, Jamison DT, Lau LJ, Murray CJ. 2001. Modeling the effects of health on economic growth. J Health Econ 20(3):423–40. Black WC 4th, Baer CF, Antolin MF, DuTeau NM. 2001. Population genomics: genome-wide sampling of insect populations. Annu Rev Entomol 46:441–69. Bloland PB. Drug Resistance in Malaria. 2001. Geneva: World Health Organization. Bloom BR. 2002. Tuberculosis—the global view. N Engl J Med 346(19):1434–5. Bloom DE, Sachs J. 1998. Geography, Demography, and Economic Growth in Africa. Brookings Papers on Economic Activity 2:207–295. Blusch JH, Patience C, Martin U. 2002. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 9(4):242–51. Boeing. 2002. Jetliner Safety: How Safe Is Flying. [Online]. Available: http://www.boeing.com/commercial/safety/pf/pf_howsafe.html. Boete C, Koella JC. 2003. Evolutionary ideas about genetically manipulated mosquitoes and malaria control. Trends Parasitol 19(1):32–8. Boone JD, Otteson EW, McGwire KC, Villard P, Rowe JE, St Jeor SC. 1998. Ecology and demographics of hantavirus infections in rodent populations in the Walker River Basin of Nevada and California. Am J Trop Med Hyg 59(3):445–51.
OCR for page 244
Braude R, Kon SK, Porter J. 1953. Antibiotics in nutrition. Nutr Abstr Rev 23:473–95. Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. 2001. Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw–Hill Companies. Brinton LA. 1992. The epidemiology of cervical cancer—overview. In: Munoz N, Bosch FX, Shah KV, Meheus A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus. Lyon, France: International Agency for Research in Cancer. Pp. 3–23. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, de Britton RC, Garcia M, Rawls WE. 1989a. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 44(2):199–203. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. 1989b. Parity as a risk factor for cervical cancer. Am J Epidemiol 130(3):486–96. Bryan FL. 1982. Diseases transmitted by foods (A classification and summary). 2nd edition. U.S. Department of Heath and Human Services, Centers for Disease Control. Atlanta: HHS Pub No. (CDC) 84–8237. Burton EC, Nemetz PN. 2000. Medical error and outcomes measures: where have all the autopsies gone? MedGenMed E8. Buzby JC, Roberts T. 1997. Economic costs and trade impacts of microbial foodborne illness. World Health Stat Q 50(1–2):57–66. Cairns L, Blythe D, Kao A, Pappagianis D, Kaufman L, Kobayashi J, Hajjeh R. 2000. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 30(1):61–4. Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH. 2002. Host genetic polymorphism analysis in cervical cancer. Clin Chem 48(8): 1218–24. Calisher CH, Root JJ, Mills JN, Beaty BJ. 2002. Assessment of ecologic and biologic factors leading to hantavirus pulmonary syndrome, Colorado, U.S.A. Croat Med J 43(3):330–7. Campbell LA, Kuo CC, Grayston JT. 1998. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4(4):571–9. Campsmith ML, Nakashima AK, Jones JL. 2000. Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. J Acquir Immune Defic Syndr 25(2):192–8. Candinas D, Adams DH. 2000. Xenotransplantation: postponed by a millennium? QJM 93(2):63–6. Carpenter C, Fayer R, Trout J, Beach MJ. 1999. Chlorine disinfection of recreational water for Cryptosporidium parvum. Emerg Infect Dis 5(4):579–84. Carter R. 2001. Transmission blocking malaria vaccines. Vaccine 19(17–19):2309–14. Cassell GH. 1998. Infectious causes of chronic inflammatory diseases and cancer. Emerg Infect Dis 4(3):475–87. Cassell GH, Waites KB, Crouse DT. 1994. Mycoplasmal infections. In: Remington JS, KLein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia: WB Saunders Co. Pp. 619-656. Castro-Leal F, Dayton J, Demery L, Mehra K. 2000. Public spending on health care in Africa: do the poor benefit? Bull World Health Org 78(1):66–74. CDC. 1983. Epidemiologic notes and reports interstate importation of measles following transmission in an airport—California, Washington, 1982. MMWR 32(16):215–216. CDC. 1984. Cryptosporidiosis among children attending day care centers—Georgia, Pennsylvania, Michigan, California, New Mexico. MMWR 33(42):599–601. CDC. 1994a. Coccidioidomycosis following the Northridge Earthquake—California, 1994. MMWR 43(10):194–5.
OCR for page 245
CDC. 1994b. Outbreak of pneumonia associated with a cruise ship, 1994. MMWR 43(28): 521. CDC. 1994c. Update: outbreak of Legionnaires’ disease associated with a cruise ship, 1994. MMWR 43(31):574–5. CDC. 1994d. Update: human plague—India, 1994. MMWR 43(41):761–2. CDC. 1995a. Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. MMWR 44(19):381– 2. CDC. 1995b. Update: outbreak of Ebola viral hemorrhagic fever—Zaire, 1995. MMWR 44(25):468–9, 475. CDC. 1997a. Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996. MMWR 46(27):624–6. CDC. 1997b. Update: Staphylococcus aureus with reduced susceptibility to vancomycin— United States, 1997. MMWR 46(35):813–5. CDC. 1997c. Update: influenza activity—United States, 1997–1998 season. MMWR 46(46): 1094–8. CDC. 1998a. Outbreak of Vibrio parahaemolyticus infections associated with eating raw oysters—Pacific Northwest, 1997. MMWR 47(22):457–62. CDC. 1998b. Report to the State of Iowa Department of Public Health on the Investigation of the Chemical and Microbial Constituents of Ground and Surface Water Proximal to Large–Scale Swine Operations. Atlanta, GA: Centers for Disease Control and Prevention. CDC. 1998c. Preventing emerging infectious diseases: a strategy for the 21st century. Overview of the updated CDC plan. MMWR 47(No. RR-15):1–14. CDC. 1998d. Rubella among crew members of commercial cruise ships––Florida, 1997. MMWR 46(52–53):1247–50. CDC. 1999a. Resurgent bacterial sexually transmitted disease among men who have sex with men—King County, Washington, 1997–1999. MMWR 48(35):773–7. CDC. 1999b. Increases in unsafe sex and rectal gonorrhea among men who have sex with men—San Francisco, California, 1994–1997. MMWR 48(3):45–8. CDC. 1999c. Outbreaks of Shigella sonnei infection associated with eating fresh parsley— United States and Canada, July–August 1998. MMWR 48(14):285–9. CDC. 2000a. HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention. 12(2):1–44. CDC. 2000b. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 49(RR–4):1–14. CDC. 2000c. Outbreak of Rift Valley fever—Yemen, August–October 2000. MMWR 49(47): 1065–6. CDC. 2000d. Serogroup W135 meningococcal disease among travelers returning from Saudi Arabia––United States, 2000. MMWR 49(16):345–6. CDC. 2000e. Monitoring hospital-acquired infections to promote patient safety—United States, 1990–1999. MMWR 49(8):149–53. CDC. 2000f. Integration Project: National Electronic Disease Surveillance System. [Online]. Available: http://www.cdc.gov/od/hissb/act_int.htm [accessed January 31, 2003]. CDC. 2001a. HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention. MMWR 13(2):1–44. CDC. 2001b. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, 2000. MMWR 50(42):919–22. CDC. 2001c. Cancer Prevention and Control: Breast and Cervical Cancer Facts. The National Breast and Cervical Cancer Early Detection Program. [Online]. Available: http://www.cdc.gov/cancer/nbccedp/anniversary/facts.htm [accessed February 21, 2003].
OCR for page 246
CDC. 2001d. Outbreak of acute respiratory febrile illness among college students—Acapulco, Mexico, March 2001. MMWR 50(14):261–2. CDC. 2001e. Mycotic Disease Listing. National Center for Infectious Diseases–Division of Bacterial and Mycotic Diseases. [Online]. Available: http://www.cdc.gov/ncidod/dbmd/ [accessed February 21, 2003]. CDC. 2001f. Sexually Transmitted Diseases Surveillance, 2000. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. CDC. 2001g. Risk for meningococcal disease associated with the Hajj 2001. MMWR 50(6): 97–8. CDC. 2001h. Update: assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR 50(12 ):221–2. CDC. 2001i. Influenza B virus outbreak on a cruise ship—Northern Europe, 2000. MMWR 50(8):137–40. CDC. 2001j. Importation of Nonhuman Primates: Foreign Quarantine regulations Relating to NHP (42CFR71.53). [Online]. Available: http://www.cdc.gov/ncidod/dq/nonhuman.htm [accessed February 18, 2003]. CDC. 2001k. Measles History. National Immunization Program. [Online]. Available: http://www.cdc.gov/nip/diseases/measles/history.htm [accessed February 18, 2003]. CDC. 2001l. Unexplained deaths following knee surgery—Minnesota, November 2001. MMWR 50(46):1035–6. CDC. 2001m. Dengue Fever: CDC Dengue Fever Home Page. [Online]. Available: http://www.cdc.gov/ncidod/dvbid/dengue/ [accessed February 18, 2003]. CDC. 2001n. The Autopsy, Medicine, and Mortality Statistics. National Center for Health Statistics. Vital Health Stat 3(32). CDC. 2001o. Public Health Action Plan to Combat Antimicrobial Resistance. National Center for Infectious Diseases, Centers for Disease Control and Prevention. Atlanta, GA [Online]. Available: http://www.cdc.gov/drugresistance/actionplan/html/index.htm [accessed January 30, 2003]. CDC. 2002a. Epidemiology and Prevention of Vaccine—Preventable Diseases. Washington, DC : Public Health Foundation. CDC. 2002b. Smallpox Overview. [Online]. Available: http://www.bt.cdc.gov/agent/smallpox/overview/overview.pdf [accessed February 21, 2003]. CDC. 2002c. Local transmission of Plasmodium vivax Malaria—Virginia, 2002. MMWR 51:931–923. CDC. 2002d. Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR 51(26):565–7. CDC. 2002e. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae—Hawaii and California, 2001. MMWR 51(46):1041–1044. CDC. 2002f. Drug-Associated HIV Transmission Continues in the United States. National Center for HIV, STD and TB Prevention–Division of HIV/AIDS Prevention. [Online]. Available: http://www.cdc.gov/hiv/pubs/facts/idu.htm [accessed February 14, 2003]. CDC. 2002g. Trends in sexual risk behaviors among high school students—United States, 1991–2001. MMWR 51(38):856–9. CDC. 2002h. Sexually Transmitted Disease Surveillance, 2001. Atlanta: U.S. Department of Health and Human Services. CDC. 2002i. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR 51(43 ):973–4. CDC. 2002j. Update: allograft-associated bacterial infections—United States, 2002. MMWR 51(10):207–10. CDC. 2002l. Malaria surveillance—United States, 2000. MMWR 51(SS05):9–21.
OCR for page 247
CDC. 2002m. Outbreaks of gastroenteritis associated with noroviruses on cruise ships— United States, 2002. MMWR 51(49):1112–5. CDC. 2002n. The National Molecular Subtyping Network for Foodborne Disease Surveillance. [Online]. Available: http://www.cdc.gov/pulsenet/index.htm [accessed February 18, 2003]. CDC. 2002o. Press Release: CDC Releases New Hand-Hygiene Guidelines. [Online]. Available: www.cdc.gov/od/oc/media/pressrel/r021025.htm [accessed February 18, 2003]. CDC. 2002p. Measles—United States, 2000. MMWR 51(6):120–3. CDC. 2002q. Press Release: Measles no longer endemic in the United States. [Online]. Available: http://www.cdc.gov/od/oc/media/pressrel/r020429.htm [accessed February 21, 2003]. CDC. 2002r. Protecting the Nation’s health in an Era of Globalization. CDC’s Global Infectious Disease Strategy. Atlanta, GA: Center for Disease Control and Prevention. CDC. 2002s. Programs in Brief Epidemic Information Exchange (Epi–X). [Online]. Available: http://www.cdc.gov/programs/research5.htm [accessed January 30, 2003]. CDC. 2002t. National Electronic Disease Surveillance System. [Online]. Available: http://www.cdc.gov/nedss/ [accessed January 31, 2003]. CDC. 2002u. National Center for Infectious Diseases: Surveillance Resources, Emerging Infections Program. [Online]. Available: http://www.cdc.gov/ncidod/osr/EIP.htm [accessed January 30, 2003]. CDC. 2002v. Special Pathogens Branch, Division of Viral and Rickettsial Diseases, unpublished data. CDC. 2002w. New Variant CJD: Fact Sheet. [Online]. Available: http://www.cdc.gov/od/oc/media/pressrel/fs020418.htm [accessed February 27, 2003]. CDC. 2002x. All About Hantavirus. National Center for Infectious Diseases–Special Pathogens Branch. [Online]. Available: http://www.cdc.gov/ncidod/diseases/hanta/hps/noframes/hpsslideset/index.htm [accessed March 4, 2003]. CDC. 2003a. Biological Diseases/Agents. [Online]. Available: http://www.bt.cdc.gov/agent/agentlist.asp#categoryadiseases [accessed February 21, 2003]. CDC. 2003b. Nationally Notifiable Infectious Diseases. [Online]. Available: http://www.cdc.gov/epo/dphsi/PHS/infdis.htm [accessed January 30, 2003]. CDC. 2003c. West Nile Virus Update: Current Case Count. [Online]. Available: http://www.cdc.gov/od/oc/media/wncount.htm [accessed February 27, 2003]. Center for Infectious Disease Research and Policy (CIDRAP). 2002. Providing a Framework for Public Health Bioterrorism Preparedness: Public Health Workforce, Collaboration, and Infrastructure Issues. Washington, DC. [Online]. Available: http://www1.umn.edu/cidrap/center/mission/papers/btworkforce.html [accessed January 30, 2003]. Center for Science in the Public Interest (CSPI). 1998. Protecting the Crown Jewels: A Strategic Plan to Preserve the Effectiveness of Antibiotics. [Online]: Available: http://www.cspinet.org/reports/abiotic.htm [accessed January 30, 2003]. Chamberland ME, Epstein J, Dodd RY, Persing D, Will RG, DeMaria A Jr, Emmanuel JC, Pierce B, Khabbaz R. 1998. Blood safety. Emerg Infect Dis 4(3):410–1. Chamberland ME, Alter HJ, Busch MP, Nemo G, Ricketts M. 2001. Emerging infectious disease issues in blood safety. Emerg Infect Dis 7(3 Suppl):552–3. Chambers HF. 2001. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7(2):178–82. Chandra RK. 1997. Nutrition and the immune system: an introduction. Am J Clin Nutr 66(2):460S–463S. Chandrasekaran S, Lalithakumari D. 1998. Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens. J Med Microbiol 47(3):197–200. Chapman LE, Bloom ET. 2001. Clinical xenotransplantation. JAMA 285(18):2304–6.
OCR for page 248
Chee–Sanford JC, Aminov RI, Krapac IJ, Garrigues–Jeanjean N, Mackie RI. 2001. Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Appl Environ Microbiol 67(4):1494–502. Chen DK, McGeer A, de Azavedo JC, Low DE. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 341(4):233–9. Chen Z, Ge Y, Landman N, Kang JX. 2002a. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. BMC Cancer 2(1):18. Chen SY, Gibson S, Katz MH, Klausner JD, Dilley JW, Schwarcz SK, Kellogg TA, McFarland W. 2002b. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999–2001, USA. Am J Pub Health 92(9):1387–8. Childs JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, Gage KL, Rollin PE, Sarisky J, Enscore RE, et al. 1994. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 169(6):1271–80. Chin J, ed. 2000. Control of Communicable Diseases Manual. 17th ed. Washington, DC: American Public Health Association. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, et al. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288(5470):1432–5. Chukwuani CM. 1999. Socio-economic implication of multi-drug resistant malaria in the community; how prepared is Nigeria for this emerging problem? West Afr J Med 18(4): 303–6. Cohen ML. 2000. Changing patterns of infectious disease. Nature 406(6797):762–7. Coker R. 2001. Control of tuberculosis in Russia. Lancet 358(9280):434–5. Cole LA. 1997. The Eleventh Plague: The Politics of Biological and Chemical Warfare. New York: WH Freeman and Company. Connolly M, Programme on Communicable Diseases in Complex Emergencies. 2002. Communicable diseases. Action Against Infection: A Newsletter for the World Health Organization and Its Partners 3(2):1–4. Conway DJ, Roper C. 2000. Micro-evolution and emergence of pathogens. Int J Parasitol 30(12–13):1423–30. Cooper RS, Osotimehin B, Kaufman JS, Forrester T. 1998. Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351(9097):208–10. Coughlan E, Mindel A, Estcourt CS. 2001. Male clients of female commercial sex workers: HIV, STDs and risk behaviour. Int J STD AIDS 12(10):665–9. Cox NJ, Subbarao K. 2000. Global epidemiology of influenza: past and present. Annu Rev Med 51:407–21. Cunningham-Rundles S and Nesin M. 2000. Bacterial infections in the immunocompromised host. In: Nataro J, Blaser M, Cunningham-Rundles S, eds. Persistent Bacterial Infections. Washington, DC: ASM Press. Pp. 145–163. Daar AS. 1999. Animal-to-human organ transplants—a solution or a new problem? Bull World Health Organ 77(1):54–61. Danesh J, Newton R, Beral V. 1997. Epidemiology. A human germ project? Nature 389(6646):21, 23–4. Davis CJ. 1999. Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq. Emerg Infect Dis 5(4):509–12.
OCR for page 249
Davis R, Kimball AM. 2001. The economics of emerging infections in the Asia Pacific region: what do we know and what do we need to know? In: Price-Smith AT, ed. Plagues and Politics: Infectious Disease and International Policy. New York: Palgrave Macmillan. Day JF, Duxbury CV, Glasscock S, Pganessi JE. 2001. Removal trapping for the control of coastal biting midge populations. Technical Bulletin Florida Control Association 3:15– 16. De Grandis SA, Stevenson RM. 1985. Antimicrobial susceptibility patterns and R plasmid– mediated resistance of the fish pathogen Yersinia ruckeri. Antimicrob Agents Chemother 27(6):938–42. de The G. 1995. Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect 103 Suppl 8:269–73. De Tott F. 1973. Memoirs of Baron De Tott. New York: Arno Press. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285(21):2763–73. Denver Summit of the Eight. 1997. Communique. Denver, June 22, 1997. [Online] Available: http://usinfo.state.gov/topical/econ/group8/summit97/document.htm [accessed January 30, 2003]. Department of Defense–Global Emerging Infections System (DoD–GEISWeb). 2002. ESSENCE: Web Instructions. Electronic Surveillance System for the Early Notification of Community–Based Epidemics. [Online]. Available: http://www.geis.ha.osd.mil/GEIS/SurveillanceActivities/ESSENCE/ESSENCEinstructions.asp [accessed January 30, 2003]. DHHS (U.S. Department of Health and Human Services). 2000a. HHS Fact Sheet. HHS Guidelines for Xenotransplantation Safety. [Online]. Available: http://www.hhs.gov/news/press/2000pres/20000526.html [accessed March 4, 2003]. DHHS. 2000b. Healthy People 2010:2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office. DHHS, CDC, NIH. 1999. Biosafety in Microbiological and Biomedical Laboratories. 4th ed. HHS Publication No. (CDC) 93–8395. Washington, DC: U.S. Government Printing Office. Diaz-Bonilla E, Babinard J, Pinstrup–Anderson P. 2001. Globalization and Health: A Survey of Opportunities and Risks for the Poor in Developing Counties. CMH Working Paper Series No. WG4:11. Cambridge, MA: Commission on Globalization and Health. DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. 1991. Cost of innovation in the pharmaceutical industry. J Health Econ 10(2):107–42. Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. 1996. Fungal infections: a growing threat. Public Health Rep 111(3):226–35. Dixon S, McDonald S, Roberts J. 2002. The impact of HIV and AIDS on Africa’s economic development. BMJ 324(7331):232–4. Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, Li N, Wenzel RP. 1992. Comparative efficacy of alternative hand–washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 327(2):88–93. Dumler JS, Valsamakis A. 1999. Molecular diagnostics for existing and emerging infections. Complementary tools for a new era of clinical microbiology. Am J Clin Pathol 112(Suppl 1):S33–9. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–86.
OCR for page 250
Dyke MP, Grauaug A, Kohan R, Ott K, Andrews R. 1993. Ureaplasma urealyticum in a neonatal intensive care population. J Paediatr Child Health 29(4):295–7. Eandi M, Zara GP. 1998. Economic impact of resistance in the community. Int J Clin Pract Suppl 95:27–38. Economic Research Service. 2001. U.S. Department of Agriculture. Research Emphasis–food safety: features. [Online]. Available: http://www.ers.usda.gov/emphases/safefood/features.htm [accessed February 3, 2003]. Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD. 1994. Intersecting epidemics—crack cocaine use and HIV infection among inner–city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 331(21):1422–7. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. 1999. Nosocomial bloodstream infections in United States hospitals: a three–year analysis. Clin Infect Dis 29(2):239–44. Effler P, Ching–Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. 1999. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods . JAMA 282(19):1845–50. Ekeus R. 1999. Biological inspections in Iraq. In: Drell SD, Sofaer AD, Wilson GD, eds. The New Terror: Facing the Threat of Biological and Chemical Weapons. Stanford, CA: Hoover Institution Press. Pp. 237–254. El Alamy MA, Cline BL. 1977. Prevalence and intensity of Schistosoma haematobium and S. mansoni infection in Qalyub, Egypt. Am J Trop Med Hyg 26(3):470–2. Elder RO, Keen JE, Siragusa GR, Barkocy–Gallagher GA, Koohmaraie M, Laegreid WW. 2000. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc Natl Acad Sci U S A 97(7):2999– 3003. Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M, Goldsmith CS, Humphrey CD, Zaki SR, Krebs JW, et al. 1994. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 51(1):102–8. Emborg H, Ersboll AK, Heuer OE, Wegener HC. 2001. The effect of discontinuing the use of antimicrobial growth promoters on the productivity in the Danish broiler production. Prev Vet Med 50(1–2):53–70. Epstein SE, Zhou YF, Zhu J. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100(4):e20–8. Esiobu N, Armenta L, Ike J. 2002. Antibiotic resistance in soil and water environments. Int J Environ Health Res 12(2):133–44. FAO (Food and Agriculture Organization of the United Nations). 2001. FAO Global Information and Early Warning System (GIEWS). Food supply situation and crop prospects in sub-Saharan Africa. Africa Report. No.1. Rome: FAO/GIEWS. Farmer P. 1996. Social inequalities and emerging infectious diseases. Emerg Infect Dis 2(4): 259–69. Fauci AS. 2001. Infectious diseases: considerations for the 21st century. Clin Infect Dis 32(5):675–85. Fayer R. 2000. Presidential address. Global change and emerging infectious diseases. J Parasitol 86(6):1174–81. Fayer R, Ungar BL. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 50(4): 458–83. FDA (Food and Drug Administration). 2000. FDA Task Force on Antimicrobial Resistance: Key Recommendations and Report. Washington, DC. [Online]. Available: http://www.fda.gov/oc/antimicrobial/taskforce2000.html [accessed January 30, 2003].
OCR for page 251
FDA. 2001. Antibiotic resistance from down on the chicken farm. FDA Consumer Magazine. [Online]. Available: http://www.fda.gov/fdac/features/2001/101_chic.html [accessed March 4, 2003]. Federation of American Scientists (FAS). 2002. Crimean–Congo Hemorrhagic Fever and America’s War on Terrorism. [Online]. Available: http://www.fas.org/ahead/disease/cchf/outbreak/2001afg.htm [accessed February 10, 2003]. Feldman M, Cryer B, McArthur KE, Huet BA, Lee E. 1996. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 110(4):1043–52. Fey PD, Safranek TJ, Rupp ME, Dunne EF, Ribot E, Iwen PC, Bradford PA, Angulo FJ, Hinrichs SH. 2000. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 342(17):1242–9. Field AK, Laughlin CA. 1999. In: Granoff A, Webster R, eds. Encyclopedia of Virology, vol. 1. 2nd ed. San Diego, CA: Academic Press. Pp. 54–68. Fine A, Layton M. 2001. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis 32(2):277–82. Fisher-Hoch SP, Tomori O, Nasidi A, Perez–Oronoz GI, Fakile Y, Hutwagner L, McCormick JB. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311(7009):857–9. Fleming DT, Wasserheit JN. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75(1):3–17. Flint J, Harding RM, Boyce AJ, Clegg JB. 1993. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 6(1):215–62. Focks DA, Daniels E, Haile DG, Keesling JE. 1995. A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg 53(5):489–506. Fonseca DM, Campbell S, Crans WJ, Mogi M, Miyagi I, Toma T, Bullians M, Andreadis TG, Berry RL, Pagac B, Sardelis MR, Wilkerson RC. 2001. Aedes (Finlaya) japonicus (Diptera: Culicidae), a newly recognized mosquito in the United States: analyses of genetic variation in the United States and putative source populations. J Med Entomol 38(2): 135–46. Foy BD, Killeen GF, Magalhaes T, Beier JC. In press. Immunological targeting of critical insect antigens. Amer Entomol. Francis E. 1921. Tularaemia: Francis 1921. I. The occurrence of tularemia in nature as a disease of Man. Public Helth Rep 36:1731–8. Franco EL, Duarte–Franco E, Ferenczy A. 2001. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164(7):1017–25. Frank B. 2000. An overview of heroin trends in New York City: past, present and future. Mt Sinai J Med 67(5–6):340–6. French GL, Ling J, Chow KL, Mark KK. 1987. Occurrence of multiple antibiotic resistance and R–plasmids in gram–negative bacteria isolated from faecally contaminated freshwater streams in Hong Kong. Epidemiol Infect 98(3):285–99. Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol 66(5):365–78. Galambos L, Sewell JE. 1995. Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895–1995. New York: Cambridge University Press. Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, Courvalin P. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 337(10):677–80. Gant V, Parton S. 2000. Community-acquired pneumonia. Curr Opin Pulm Med 6(3):226– 33.
OCR for page 266
Qiu H, Jun HW, McCall JW. 1998. Pharmacokinetics, formulation, and safety of insect repellent N,N-diethyl-3-methylbenzamide (deet): a review . J Am Mosq Control Assoc 14(1):12–27. Ramalingaswami V. 1996. The plague outbreaks of India, 1994—a prologue. Current Science 71:781–806. Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. 2000. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283(20):2680–5. Rappuoli R, Miller HI, Falkow S. 2002. Medicine. The intangible value of vaccination. Science 297(5583):937–9. Rastogi S, Kapur S, Salhan S, Mittal A. 1999. Chlamydia trachomatis infection in pregnancy: risk factor for an adverse outcome. Br J Biomed Sci 56(2):94–8. Ray AJ, Hoyen CK, Taub TF, Eckstein EC, Donskey CJ. 2002. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA 287(11):1400–1. Raymond M, Chevillon C, Guillemaud T, Lenormand T, Pasteur N. 1998. An overview of the evolution of overproduced esterases in the mosquito Culex pipiens. Philos Trans R Soc Lond B Biol Sci 353(1376):1707–11. Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski EB, Chaudhary AG, Fox AJ, Duff GW. 2000. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 182(5):1557–60. Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. 1987. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 316(11):673–6. Regis L, Silva-Filha MH, Nielsen-LeRoux C, Charles JF. 2001. Bacteriological larvicides of dipteran disease vectors. Trends Parasitol 17(8):377–80. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354(9179):635–9. Ribera E, Miro JM, Cortes E, Cruceta A, Merce J, Marco F, Planes A, Pare JC, Moreno A, Ocana I, Gatell JM, Pahissa A. 1998. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 158(18):2043–50. Rice AL, Sacco L, Hyder A, Black RE. 2000. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ 78(10):1207–21. Richman DD. 2001. HIV chemotherapy. Nature 410(6831):995–1001. Ritzinger FR. 1965. Disease transmission by aircraft. Aeromed Rev 4:1–10. Roberts DR, Laughlin LL, Hsheih P, Legters LJ. 1997. DDT, global strategies, and a malaria control crisis in South America. Emerg Infect Dis 3(3):295–302. Roberts DR, Alecrim WD, Hshieh P, Grieco JP, Bangs M, Andre RG, Chareonviriphap T. 2000. A probability model of vector behavior: effects of DDT repellency, irritancy, and toxicity in malaria control. J Vector Ecol 25(1):48–61. Roberts L. 2001. Mortality in Eastern Republic of Congo: Results from Eleven Mortality Surveys. [Online]. Available: www.intrescom.org/docs/mortality_2001/mortII_report.pdf [accessed February 8, 2002]. Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T. 2000. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85(1):432–40. Rosebury T. 1947. Experimental Airborne Infection. Baltimore: Williams and Wilkins. Rousseau JJ. 1993. The Social Contract, 3rd ed. Trans. Henry J. Tozer. London: J.M. Dent.
OCR for page 267
Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. 1999. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 5(1):9–17. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, et al. 1995. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376(6537):246–9. Saade C, Bateman M, Bendahmane D. The Story of a Successful Public–Private Partnership in Central America: Handwashing for Diarrheal Disease Prevention. 2001. Arlington, VA: Basic Support for Child Survival Project (BASICS II), Environmental Health Project, United Nations Children’s Fund, United States Agency for International Development, World Bank. Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. 1984. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 59(11): 1034–7. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2(8618): 983–6. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116(4): 273–8. Sanchez J, Comerford M, Chitwood DD, Fernandez MI, McCoy CB. 2002. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care 14(3):391–8. Sandia National Laboratories. 2002. Rapid Syndrome Validation Project (RSVP). User’s Manual and Description. DRAFT Version 2.3, 7/21/02. Albuquerque, New Mexico. [Online]. Available: http://rsvp.sandia.gov/ [accessed January 30, 2003]. Sbarbaro J. 2000. Trade Liberalization in Health Insurance: Opportunities and Challenges: The Potential Impact of Introducing or Expanding the Availability of Private Health Insurance Within Low and Middle Income Countries. Commission on Macro Economics and Health. Geneva: WHO. Schiffman MH, Brinton LA. 1995. The epidemiology of cervical carcinogenesis. Cancer 76(10 Suppl):1888–901. Schmaljohn C, Hjelle B. 1997. Hantaviruses: a global disease problem. Emerg Infect Dis 3(2):95–104. Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, Gunn RA, McNeil MM, Pinner RW, Baron RC, Burger RC, Hutwagner LC, Crump C, Kaufman L, Reef SE, Feldman GM, Pappagianis D, Werner SB. 1997. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 277(11):904–8. Schoepf BG. 2001. International AIDS research in anthropology: taking a critical perspective on the crisis. Ann Rev Anthropol 30:335–61. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342(1):15–20. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Lefkowitz L, Danila R, Stefonek K, Barrett N, Morse D, Pinner R. 2001. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 7(1):92–9. Schwarcz SK, Kellogg TA, McFarland W, Louie B, Klausner J, Withum DG, Katz MH. 2002. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 186(7):1019–22.
OCR for page 268
Scott TW, Takken W, Knols BG, Boete C. 2002. The ecology of genetically modified mosquitoes. Science 298(5591):117–9. Sealy DP, Schuman SH. 1983. Endemic giardiasis and day care. Pediatrics 72(2):154–8. Seas C, Gotuzzo E. 2000. Gram-negative bacilli. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone. Seggev JS, Lis I, Siman-Tov R, Gutman R, Abu–Samara H, Schey G, Naot Y. 1986. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 57(4):263–5. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. 1994. Maternal vitamin A deficiency and mother-to-child transmission of HIV–1. Lancet 343(8913):1593–7. Sen A. 1981. Poverty and Famines: An Essay on Entitlement and Deprivation. Oxford and New York: Oxford University Press. Sen A. 1999. Development as Freedom. New York: Anchor. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. 1997. Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr Infect Dis J 16(7):651–6. Shah KV. 1997. Human papillomaviruses and anogenital cancers. N Engl J Med 337(19): 1386–8. Shaman J, Day JF, Stieglitz M. 2002. Drought-induced amplification of Saint Louis encephalitis virus, Florida. Emerg Infect Dis 8(6):575–80. Shaw DM, Gaerthe B, Leer RJ, Van Der Stap JG, Smittenaar C, Heijne Den Bak–Glashouwer M, Thole JE, Tielen FJ, Pouwels PH, Havenith CE. 2000. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 100(4):510–8. Shieh WJ, Guarner J, Layton M, Fine A, Miller J, Nash D, Campbell GL, Roehrig JT, Gubler DJ, Zaki SR. 2000. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis 6(4):370–2. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. 2001. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 67(2):561–8. Sidell FR, Takafuji ET, Franz DR, eds. 1997. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, United States Army. Simon PA, Thometz E, Bunch JG, Sorvillo F, Detels R, Kerndt PR. 1999. Prevalence of unprotected sex among men with AIDS in Los Angeles County, California 1995–1997. AIDS 13(8):987–90. Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, Paton S. 2001. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance . CMAJ 165(1):21–6. Simpson VR. 1992. Cryptosporidiosis in newborn red deer (Cervus elaphus). Vet Rec 130(6): 116–8. Sina BJ, Aultman K. 2001. Resisting resistance. Trends Parasitol 17(7):305–6. Sinard JH. 2001. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol 70(3):333–43. Singh N. 2000. Infections in solid organ transplant recipients. Curr Opin Infect Dis 13(4):343– 347. Smith DL, Harris AD, Johnson JA, Silbergeld EK, Morris JG Jr. 2002. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci U S A 99(9):6434–9.
OCR for page 269
Smithson AE. 2000. Rethinking the Lessons of Tokyo. In: Smithson AE, Levy LA, eds. Ataxia: The Chemical and Biological Terrorism Threat and the US Response. Stimson Center Report No. 35. Washington, DC: The Henry L. Stimson Center. Spielman A. 1994. A commentary on research needs for monitoring and containing emergent vector-borne infections. Disease in Evolution: Global Changes and Emergence of Infectious Diseases. Ann NY Acad Sci 740:457–461. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979–1987. The Pneumococcal Surveillance Working Group. J Infect Dis 163(6):1273–8. Srivastava P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20:395–425. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin–10. Science 289(5483):1352–5. Stephens DS, Levin B, Halloran ME. 1998. Symposium on population biology, evolution, and control of infectious diseases. Introduction. Am J Med Sci 315(2):63. Stocker K, Waitzkin H, Iriart C. 1999. The exportation of managed care to Latin America. N Engl J Med 340(14):1131–6. Strausbaugh LJ. 2001. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis 7(2):268–71. Stuver SO, Boschi–Pinto C, Trichopoulos D. 1997. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ (138):319–24. Su X. 2002. Gonococcal resistance to ciprofloxacin and its clinical significance. 12th IUSTI Asia–Pacific Congress on STI, HIV/AIDS. Beijing, 2002. Abstract no. SY103. Pp. 55–56. Su X, Lind I. 2001. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob Agents Chemother 45(1):117–23. Sullivan AD, Wigginton J, Kirschner D. 2001. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc Natl Acad Sci U S A 98(18):10214–9. Summerfield D. 1997. The social, cultural and political dimensions of contemporary war. Med Confl Surviv 13(1):3–25. Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7(3):382–9. Swartz MN. 2002. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis 34 (Suppl 3):S111–22. Szucs T. 2000. Cost–benefits of vaccination programmes. Vaccine 18 (Suppl 1):S49–51. Tabachnick WJ, Wallis GP, Aitken TH, Miller BR, Amato GD, Lorenz L, Powell JR, Beaty BJ. 1985. Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations. Am J Trop Med Hyg 34(6):1219–24. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356(9248):2159. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. 2001. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 356(1416):1829–39. Taylor LH, Latham SM, Woolhouse ME. 2001a. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356(1411):983–9.
OCR for page 270
Taylor MT, Belgrader P, Furman BJ, Pourahmadi F, Kovacs GT, Northrup MA. 2001b. Lysing bacterial spores by sonication through a flexible interface in a microfluidic system. Anal Chem 73(3):492–6. Thiery I, Baldet T, Barbazan P, Becker N, Junginger B, Mas JP, Moulinier C, Nepstad K, Orduz S, Sinegre G. 1997. International indoor and outdoor evaluation of Bacillus sphaericus products: complexity of standardizing outdoor protocols. J Am Mosq Control Assoc 13(3):218–26. Threlfall EJ, Ward LR, Frost JA, Willshaw GA. 2000. The emergence and spread of antibiotic resistance in food-borne bacteria. Int J Food Microbiol 62(1–2):1–5. Titus RG, Ribeiro JM. 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239(4845):1306–8. Tokars JI, Frank M, Alter MJ, Arduino MJ. 2002. National surveillance of dialysis–associated diseases in the United States, 2000. Semin Dial 15(3):162–71. Toole MJ, Waldman RJ. 1990. Prevention of excess mortality in refugee and displaced populations in developing countries. JAMA 263(24):3296–302. Toole MJ, Galson S, Brady W. 1993. Are war and public health compatible? Lancet 341(8854):1193–6. Topcu Z, Chiba I, Fujieda M, Shibata T, Ariyoshi N, Yamazaki H, Sevgican F, Muthumala M, Kobayashi H, Kamataki T. 2002. CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis 23(4):595–8. Topouzis D, du Guerny J. 1999. Sustainable Agriculture/Rural Development and Vulnerability to the AIDS Epidemic. Geneva: UNAIDS/FAO. Topouzis D, Hemrich G. 2000. Multi-sectoral responses to HIV/AIDS: constraints and opportunities for technical cooperation. J Intern Dev 12:85–99. Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S, Birkness KA, Skeels MR, Horan JM, Foster LR. 1997. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278(5):389–95. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358(9277):207–8. Tuazon CU, Sheagren JN. 1974. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 129(6):725–7. Tzipori S, Angus KW, Campbell I, Sherwood D. 1981. Diarrhea in young red deer associated with infection with Cryptosporidium. J Infect Dis 144(2):170–5. Umemura T, Alter HJ, Tanaka E, Yeo AE, Shih JW, Orii K, Matsumoto A, Yoshizawa K, Kiyosawa K. 2001. Association between SEN virus infection and hepatitis C in Japan. J Infect Dis 184(10):1246–51. UNAIDS. 2000. Report on the Global HIV/AIDS Epidemic: June 2000. UNAIDS/00.13E. Geneva: Joint United Nations Programme on HIV/AIDS. UNAIDS. 2001. Twenty years of HIV/AIDS in graphics. [Online]. Available: http://www.unaids.org/fact_sheets/files/AIDStwenty_en.html#graphics [accessed March 4, 2003]. UNAIDS. 2002. Report on the Global HIV/AIDS Epidemic: July 2002. UNAIDS/02.26E. Geneva: Joint United Nations Programme on HIV/AIDS. UNAIDS, WHO. 2001. AIDS Epidemic Update: December 2001. UNAIDS/01.74E—WHO/ CDS/NCS/2001.2. Geneva: Joint United Nations Programme on HIV/AIDS/World Health Organization. UNAIDS, WHO. 2002. AIDS epidemic update. UNAIDS/02.46E. Geneva Switzerland: World Health Organization.
OCR for page 271
Union of Concerned Scientists (UCS). 2002. Food and Environment: Antibiotic Resistance. http://www.ucsusa.org/food_and_environment/antibiotic_resistance/index.cfm?pageID=10. United Nations Economic Commission for Africa. 2000. African Development Forum 2000, AIDS: the Greatest Leadership Challenge HIV/AIDS and Economic Development in Sub– Saharan Africa. United Nations Economic Commission for Africa. [Online]. Available: http://www.uneca.org/adf2000/theme1.htm#1 [accessed March 5, 2003]. United Nations Popuation Division. 1999. The World at Six Billion. ESA/P/WP.154. New York: Population Division, Department of Economic and Social Affairs. United Nations Population Division. 2001. World Population Prospects: The 2000 Revision. ESA/P/WP.165. New York: United Nations. United Nations Population Division. 2002. World Urbanization Prospects: The 2001 Revision. ESA/P/WP.173. New York: Population Division, Department of Economic and Social Affairs. United Nations Population Fund (UNFPA). 1999. The State of World Population 1999. [Online]. Available: http://www.unfpa.org/swp/1999/contents.htm [accessed February 14, 2003]. UNFPA. 2001. The State of World Population 2001. [Online]. Available: http://www.unfpa.org/swp/swpmain.htm [accessed February 14, 2003]. United States Commission on National Security/21st Century. 2001. Road Map for National Security: Imperative for Change. The Phase III Report of the U.S. Commission on National Security/21st Century. University Renal Research and Education Association, United Network for Organ Sharing. 2003. 2002 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1992–2001. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation. Uppal PK. 2000. Emergence of Nipah virus in Malaysia. Ann N Y Acad Sci 916:354–7. U.S. Census Bureau. 2001. Population Profile of the United States: 2000 (Internet Release). [Online]. Available: http://www.census.gov/population/www/pop–profile/profile2000.html [accessed March 5, 2003]. U.S. Census Bureau. 2002a. United States Census 2000. [Online]. Available: http://www.census.gov/main/www/cen2000.html [accessed February 14, 2003]. U.S. Census Bureau. 2002b. Current Population Reports, P60–219, Poverty in the United States: 2001. Washington, DC: U.S. Government Printing Office. U.S. Congress, Office of Technology Assessment. 1993a. Technologies Underlying Weapons of Mass Destruction, OTA–BP–ISC–115. Washington, DC: U.S. Government Printing Office. U.S. Congress, Office of Technology Assessment. 1993b. Proliferation of Weapons of Mass Destruction: Assessing the Risks, OTA–ISC–559. Washington, DC: U.S. Government Printing Office. USDA. 1997. Part III: Changes in the U.S. Pork Industry 1990–1995 Fort Collins, CO: U.S. Department of Agriculture. USDA. 2000a. Changes in the U.S. Feedlot Industry, 1994–1999. #N327.0800. Fort Collins, CO: USDA:APHIS:VS, CEAH, National Animal Health Monitoring System. USDA. 2000b. Part III: Health Management and Biosecurity in U.S. Feedlots, 1999. #N336.1200. Fort Collins, CO: USDA:APHIS:VS, CEAH, National Animal Health Monitoring System . USDA. 2001. Part I: Reference of Swine Health and Management in the United States, 2000, National Health Monitoring System. #N338.0801. Fort Collins, CO: U.S. Department of Agriculture.
OCR for page 272
USDA, EPA. 1999. Unified National Strategy for Animal Feeding Operations. Washington, DC: U.S. Department of Agriculture, Environmental Protection Agency. Usera MA, Aladuena A, Gonzalez R, De la Fuente M, Garcia–Pena J, Frias N, Echeita MA. 2002. Antibiotic resistance of Salmonella spp. from animal sources in Spain in 1996 and 2000. J Food Prot 65(5):768–73. Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L, Hammerschlag MR. 1993. Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr Infect Dis J 12(7):571–3. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, Sacks DL, Ribeiro JM. 2001. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 194(3):331–42. van Belkum A, Verbrugh H. 2001. 40 years of methicillin resistant Staphylococcus aureus. BMJ 323(7314):644–5. Venczel LV, Desai MM, Vertz PD, England B, Hutin YJ, Shapiro CN, Bell BP. 2001. The role of child care in a community-wide outbreak of hepatitis A. Pediatrics 108(5):E78. Vicca AF. 1999. Nursing staff workload as a determinant of methicillin–resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 43(2):109–13. Vitek CR, Wharton M. 1998. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis 4(4):539–50. Volmink J, Garner P. 2001. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev (4):CD003343. Volmink J, Matchaba P, Garner P. 2000. Directly observed therapy and treatment adherence. Lancet 355(9212):1345–50. Walker JB, Hussey EK, Treanor JJ, Montalvo A Jr, Hayden FG. 1997. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. J Infect Dis 176(6):1417–22. Wallensteen P, Sollenberg M. 1999. Armed conflict, 1989–1998. J Peace Res 36(5):593–606. Wallensteen P, Sollenberg M. 2001. Armed conflict, 1989–2000. J Peace Res 38(5):629–644. Weatherall DJ. 1996a. The genetics of common diseases: the implications of population variability. Ciba Found Symp 197:300–8; discussion 308–11. Weatherall DJ. 1996b. Host genetics and infectious disease. Parasitology 112 Suppl:S23–9. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56(1):152–79. Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F. 1999. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 5(3):329–35. Wellems TE, Plowe CV. 2001. Chloroquine-resistant malaria. J Infect Dis 184(6):770–6. Wenzel RP, Edmond MB. 2001. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7(2):174–7. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. 1991. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 91(3B): 221S–227S. West CE. 2000. Vitamin A and measles. Nutr Rev 58(2 Pt 2):S46–54. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbroucke JP. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349(9046):170–3. White DG, Zhao S, Sudler R, Ayers S, Friedman S, Chen S, McDermott PF, McDermott S, Wagner DD, Meng J. 2001. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med 345(16):1147–54. Whitehead Institute. 2002. Whitehead—Who We Are. [Online]. Available: www.wi.mit.edu/who/who.html [accessed February 10, 2003].
OCR for page 273
Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343(26):1917–24. WHO. 1970. Health Aspects of Chemical and Biological Weapons. Geneva: World Health Organization. WHO. 1996. Fighting Disease, Fostering Development. The World Health Report 1996. Geneva: World Health Organization. WHO. 1997. Vitamin A Supplements: A Guide to Their Use in the Treatment of Vitamin A Deficiency and Xerophthalmia. Geneva: World Health Organization. WHO. 1998a. World Health Report 1998: Life in the 21st Century: A Vision for All. Geneva: World Health Organization. WHO. 1998b. Fact Sheets: Global Infectious Disease Surveillance. Fact Sheet No 200. Geneva: WHO. WHO. 1999a. Removing Obstacles to Healthy Development. Report on Infectious Disease. Geneva: WHO. WHO. 1999b. World Health Report 1999: Making a Difference. Geneva: World Health Organization. WHO. 1999c. Food Safety Issues Associated with Products from Aquaculture. Geneva: World Health Organization. WHO. 1999d. What Is DOTS? A Guide to Understanding the WHO-Recommended TB Control Strategy Known as DOTS. WHO/CDS/CPC/TB/99.270. Geneva: World Health Organization. WHO. 1999e. Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National and Regional Planning. Geneva: World Health Organization. WHO. 2000a. World Health Report 2000: Health Systems: Improving Performance. Geneva: World Health Organization. WHO. 2000b. Infant and young child nutrition, Report by the Director-General. Fifty-third World Health Assembly. A53/7. WHO. 2000c. Outbreak news: Rift Valley fever, Saudi Arabia, August–October 2000. Weekly Epidemiological Record 75(46):369–376. WHO. 2000d. Cholera Factsheet. Fact Sheet No 107. Geneva: World Health Organization. WHO. 2000e. Fifty-Third World Health Assembly. Stop Tuberculosis Initiative, Report by the Director General. A53/5. Geneva: World Health Organization. WHO. 2000f. WHO Global Principles for the Containment of Antimicrobial Resistance in Animals Intended for Food. Report of a WHO consultation with the participation of the Food and Agriculture Organization of the United Nations and the Office International des Epizooties. Geneva, 5–9 June 2000. WHO/CDS/CSR/APH/2000.4. WHO. 2000g. A major killer in west and central Africa. Measles Bulletin. Issue 5. WHO/ V&B/00.38. WHO. 2001a. World Health Report 2001: Global Tuberculosis Control. Geneva: World Health Organization. WHO. 2001b. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization. WHO. 2001c. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization. WHO. 2001d. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections, Overview and Estimates. WHO/HIV_AIDS/2001.02. Geneva: World Health Organization. WHO. 2001e. Nipah Virus Factsheet. Fact Sheet No 262. [Online]. Available: http://www.who.int/inf–fs/en/fact262.html [accessed February 21, 2003].
OCR for page 274
WHO. 2001f. Cholera, 2000. Wkly Epidemiol Rec 76(31):233–40. WHO. 2001g. WHO Vaccine-Preventable Diseases: Monitoring System. 2001 Global Summary. Department of Vaccines and Biologicals. WHO/V&B/01.34. Geneva: World Health Organization. WHO. 2001h. WHO and Lyon—A Partnership for Global Health Security. [Online]. Available: http://www.who.int/emc/lyon/ [accessed January30, 2003]. WHO. 2001i. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/ CDS/CSR/DRS/2001.2a. Geneva: World Health Organization. WHO. 2002a. Coordinates 2002—Charting progress against AIDS, TB and malaria. [Online]. Available: http://www.who.int/infectious-disease-news/ [accessed February 13, 2003]. WHO. 2002b. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization. WHO. 2002c. Tuberculosis. [Online]. Available: http://www.who.int/mediacentre/factsheets/who104/en/index.html [accessed February 21, 2003]. WHO. 2002d. Nutrition. [Online]. Available: http://www.who.int/nut/ [accessed February 20, 2003]. WHO. 2002e. Use of Antimicrobials Outside Human Medicine and Resultant Antimicrobial Resistance in Humans. Fact Sheet 268. Geneva: WHO. WHO. 2002f. Prevention of Hospital-Acquired Infections, A Practical Guide. Geneva: World Health Organization. WHO. 2002g. An Expanded DOTS Framework for Effective Tuberculosis Control. WHO/ CDS/TB/2002.297. Geneva: World Health Organization. WHO. 2002h. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2002. WHO/CDS/TB/2002.295. Geneva: World Health Organization. WHO. 2002i. Tuberculosis. Fact Sheet No 104. [Online]. Available: http://www.who.int/mediacentre/factsheets/who104/en/index.html [accessed February 6, 2003]. WHO. 2002j. Scaling up the Response to Infectious Diseases: A Way Out of Poverty. WHO/ CDS/2002.7. Geneva: World Health Organization. WHO. 2002k. Global measles mortality reduction and regional elimination, 2000–2001. Part II. Wkly Epidemiol Rec 77(8):58–61. WHO. 2003a. TDR Home Page. [Online]. Available: www.who.int/tdr [accessed February 28, 2003]. WHO. 2003b. Communicable Disease Surveillance & Response (CSR): Global Outbreak Alert & Response Network. [Online]. Available: http://www.who.int/csr/outbreaknetwork/en/ [accessed January 30, 2003]. WHO, UNICEF. 2001. WHO–UNICEF Joint Statement on Strategies to Reduce Measles Mortality Worldwide. Geneva: WHO. Wick RL Jr, Irvine LA. 1995. The microbiological composition of airliner cabin air. Aviat Space Environ Med 66(3):220–4. Wierup M. 2001. The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb Drug Resist 7(2):183–90. Wierzba TF, El–Yazeed RA, Savarino SJ, Mourad AS, Rao M, Baddour M, El–Deen AN, Naficy AB, Clemens JD. 2001. The interrelationship of malnutrition and diarrhea in a periurban area outside Alexandria, Egypt. J Pediatr Gastroenterol Nutr 32(2):189–96. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. 1996. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347(9006):921–5. Willadsen P. 2001. The molecular revolution in the development of vaccines against ectoparasites. Vet Parasitol 101(3–4):353–68.
OCR for page 275
Willadsen PL, Billingsley PF. 1996. Immune intervention against blood-feeding insects. In: Lehane ML, Billinsley PF, eds. Biology of the Insect Midgut. London: Chapman and Hall. Pp. 323–340. Wilson ME. 1995. Travel and the emergence of infectious diseases. Emerg Infect Dis 1(2):39– 46. Wilson ML. 1994. Rift Valley fever virus ecology and the epidemiology of disease emergence. Ann N Y Acad Sci 740:169–80. Wilson ML. 2001. Ecology and infectious disease. In: Aron JL, Patz J, eds. Ecosystem Change and Public Health: A Global Perspective. Baltimore: Johns Hopkins University Press. Wolitski RJ, Valdiserri RO, Denning PH, Levine WC. 2001. Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Pub Health 91(6):883–8. Wong D, Nye K, Hollis P. 1991. Microbial flora on doctors’ white coats. BMJ 303(6817): 1602–4. Wood R, Maartens G, Lombard CJ. 2000. Risk factors for developing tuberculosis in HIV–1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 23(1):75–80. World Bank. 2001. World Development Report: Attacking Poverty 2000/2001. New York: Oxford University Press. World Bank. 2002. World Development Indicators 2001. Washington, DC: World Bank. World Bank Group. 2002. Poverty Trends and Voices of the Poor: Income Poverty. [Online]. Available: www.worldbank.org/poverty/data/trends/income.htm [accessed February 27, 2003]. World Resources Institute, United Nations Environment Programme, United Nations Development Programme, World Bank. 1996. World Resources 1996–97. New York and Oxford: Oxford University Press. World Tourism Organization. 2002. Tourism Highlights 2002. Madrid, Spain: World Tourism Organization. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa–associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342(8871):575–7. Wright PF, Webster RG. 2001. Orthomyxoviruses. In: Knipe DM, Howley PM, eds. Fields Virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins. Pp. 1533–79. Yang S. 1998. FoodNet and Enter-net: emerging surveillance programs for foodborne diseases. Emerg Infect Dis 4(3):457–8. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. 1994. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 149(5):1348–53. Yates T, Mills J, Parmenter C, Ksiazek T, Parmenter R, Calisher C, Nichol S, Abbott K, Young J, Morrison M, Beaty B, Dunnum J, Baker RJ, Peters CJ. 2002a. The ecology and evolutionary history of an emergent disease: hantavirus pulmonry syndrome. Bioscience 52(11):989–98. Yates T, Mills J, Parmenter C, Ksiazek T, Parmenter R, Calisher C, Nichol S, Abbott K, Young J, Morrison M, Beaty B, Dunnum J, Baker RJ, Peters CJ. 2002b. Biocomplexity and hantavirus pulmonary syndrome: the ecology of an outbreak. Bioscience. Submitted. Ylitalo N, Josefsson A, Melbye M, Sorensen P, Frisch M, Andersen PK, Sparen P, Gustafsson M, Magnusson P, Ponten J, Gyllensten U, Adami HO. 2000. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60(21):6027–32. Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, de Schipper FA, Meijer CJ. 2001. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears . Br J Cancer 85(3):398–404.
OCR for page 276
This page in the original is blank.
Representative terms from entire chapter: